Prism Medico board to meet on May 28 to consider Q4 FY26 results

1 min read     Updated on 23 May 2026, 09:00 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Prism Medico and Pharmacy Limited will hold a board meeting on May 28, 2026, to approve the audited standalone financial results for the quarter and fiscal year ended March 31, 2026. The meeting will also cover the review of the Auditors Report and other routine business.

powered bylight_fuzz_icon
41095790

*this image is generated using AI for illustrative purposes only.

Prism Medico and Pharmacy Limited has announced that its board meeting is scheduled to take place on May 28, 2026. The meeting will be held at the company's registered office located at Suketi Road, Kala Amb, Sirmaur, Himachal Pradesh, starting at 3:00 PM.

The primary agenda for the meeting involves the consideration and approval of the audited standalone financial results for the company. Specifically, the board will review the performance for the quarter and financial year ended March 31, 2026, along with the Auditors Report. This disclosure is being made in compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Agenda Details

The board will deliberate on the following key points during the session:

  • Consider, approve, and take on record the Audited Standalone Financial Results for the quarter and financial year ended March 31, 2026.
  • Review the Auditors Report accompanying the financial results.
  • Discuss any other routine matters or business of the company.

Meeting Information

Details Information
Date May 28, 2026
Time 03:00 P.M.
Venue Registered Office, Suketi Road, Kala Amb, Sirmaur, Himachal Pradesh-173030
Purpose Consideration of Audited Financial Results for Q4 and FY26

The intimation regarding this meeting has been sent to the stock exchanges, including BSE Limited and Metropolitan Stock Exchange of India Limited, to ensure regulatory compliance. Shareholders and market participants can await the official announcement of the financial results following the conclusion of the board meeting.

Historical Stock Returns for Prism Medico & Pharmacy

1 Day5 Days1 Month6 Months1 Year5 Years
-4.97%-0.14%-13.67%+49.37%+69.20%+159.07%

How has Prism Medico and Pharmacy Limited's revenue and profitability trended over the past few quarters leading into FY26 results?

Will the board consider announcing any dividend distribution or capital allocation strategy following the approval of FY26 audited results?

Are there any expansion plans or strategic initiatives in the pharmaceutical sector that Prism Medico may announce alongside its annual financial results?

Prism Medico & Pharmacy
View Company Insights
View All News
like19
dislike

Prism Medico & Pharmacy Appoints Mr. Harpreet Singh as Internal Auditor for FY 2025-2026

2 min read     Updated on 11 May 2026, 07:41 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Prism Medico & Pharmacy Limited's Board of Directors, at their meeting held on May 11, 2026, approved the appointment of Mr. Harpreet Singh of M/s. S Harpreet and Associates, Chartered Accountants, as internal auditor for the financial year 2025-2026. The board meeting commenced at 04:00 P.M. and concluded at 04:30 P.M. The disclosure was made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Mr. Harpreet Singh, who has been in practice since 2018, is an associate member of the Institute of Chartered Accountants of India with expertise in direct tax, assurance, and accounting.

powered bylight_fuzz_icon
40054306

*this image is generated using AI for illustrative purposes only.

Prism Medico & Pharmacy Limited has announced the appointment of Mr. Harpreet Singh of M/s. S Harpreet and Associates, Chartered Accountants, as its internal auditor for the financial year 2025-2026. The decision was taken at a Board of Directors meeting held on May 11, 2026, and disclosed to the stock exchanges pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Board Meeting Details

The board meeting during which the appointment was approved was held at the company's registered office located at Suketi Road, Kala Amb, Sirmaur, Himachal Pradesh. The key details of the meeting and the appointment are summarised below:

Parameter: Details
Meeting Date: May 11, 2026
Meeting Commencement: 04:00 P.M.
Meeting Conclusion: 04:30 P.M.
Appointment: Internal Auditor
Appointee: Mr. Harpreet Singh
Firm Name: M/s. S Harpreet and Associates, Chartered Accountants
Applicable Period: Financial Year 2025-2026
Regulatory Disclosure: Regulation 30, SEBI (LODR) Regulations, 2015

The disclosure was signed by Davender Singh, Director (DIN: 09447213) of Prism Medico & Pharmacy Limited.

About the Appointed Auditor

Mr. Harpreet Singh is the proprietor of M/s. S Harpreet and Associates, Chartered Accountants, based in Derabassi, Punjab. He is a graduate and an associate member of the Institute of Chartered Accountants of India and has been in practice since 2018. The firm itself was established in 2019.

Mr. Harpreet Singh's areas of expertise include:

  • Direct Tax
  • Assurance and Accounting
  • Internal Audits and Risk-Based Management Audits
  • Tax Strategy and Compliance

About M/s. S Harpreet and Associates

M/s. S Harpreet and Associates offers a broad range of professional services to domestic and global businesses. The firm's service portfolio spans multiple disciplines, as outlined below:

Service Area: Key Offerings
Audit and Assurance: Statutory Audits, Tax Audits, Internal Audits, Inspection and Investigation Audits
Tax and Regulatory: Tax Planning, Compliance, Representation, International Taxation, Transfer Pricing
Indirect Tax: GST Advisory, Custom-related Advisory Services
Corporate Law Services: Incorporation, Statutory Filings, Corporate Litigation Support
Finance and Accounting Outsourcing: Accounting Processes, Client Reporting
Corporate Finance: Fund Raising, Business Valuation, Intangible Valuation

The firm emphasises core values including integrity, competence, professionalism, responsibility and accountability, simplicity, adaptability, and versatility in its service delivery.

Historical Stock Returns for Prism Medico & Pharmacy

1 Day5 Days1 Month6 Months1 Year5 Years
-4.97%-0.14%-13.67%+49.37%+69.20%+159.07%

How might the appointment of a relatively young firm (established 2019) as internal auditor impact investor confidence in Prism Medico & Pharmacy's governance standards compared to industry peers?

Could this internal audit appointment signal Prism Medico & Pharmacy's preparation for a broader compliance overhaul or potential fundraising activity in the near future?

What are the potential risks to Prism Medico & Pharmacy if M/s. S Harpreet and Associates, given its limited operational history, identifies significant internal control weaknesses during FY 2025-2026?

Prism Medico & Pharmacy
View Company Insights
View All News
like20
dislike

More News on Prism Medico & Pharmacy

1 Year Returns:+69.20%